Hong Kong Drug Office has updated and included the latest set of frequently asked questions (FAQs) on their official website in August 2021. However, the information was only made available for public view at the end of November.
The page for FAQs covers a range of topics, which are general information, registration of pharmaceutical products, clinical trial, import/export of pharmaceutical products, licensing, and other relevant topics. There are 51 questions available for the industry’s reference.
One of the general questions is about the difference in the control between Western medicine and Chinese medicine in Hong Kong, where Western medicine refers to pharmaceutical product as defined in the Pharmacy and Poisons Ordinance (Cap. 138). As for Chinese medicine, it is controlled under Chinese Medicine Ordinance (Cap. 549).
Another example of the information presented in the page is about expired medicines, whereby licensed pharmaceutical traders are required to register with the Environmental Protection Department as a Chemical Waste Producer. The expired medicines will then need to be disposed by an authorized chemical waste collector.
More details can be found in “Frequently Asked Questions (Hong Kong Drug Office), August 2021”: https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/guidelines_forms/faq.html